Autres langues Dr. Lal PathLabs Limited

Actions

LALPATHLAB

INE600L01024

Installations et services en soins de santé

Marché Fermé - NSE India S.E. Autres places de cotation 13:05:07 12/06/2026			Varia. 5j.	Varia. 1 janv.
1 601,50 ^INR	+0,50%		+4,20%	+8,02%

04/05	DR. LAL PATHLABS LIMITED : Nomura toujours à l'achat	ZM
01/05	Dr. Lal PathLabs Limited (NSEI:LALPATHLAB) a finalisé l'acquisition de Shahbazkers Diagnostic Centre Private Limited.	CI

Autres langues

01/05	Dr. Lal PathLabs Limited completed the acquisition of Shahbazkers Diagnostic Centre Private Limited.
30/04	India's Dr Lal Path Labs posts quarterly profit fall on tax expense
30/04	Lal PathLabs to buy 100% stake in ShahbazKers Diagnostic Centre
30/04	Lal PathLabs March-quarter consol net profit 1.31 billion rupees
30/04	India's Dr Lal Path Labs posts quarterly profit fall on tax expense
30/04	Dr. Lal Pathlabs Limited Approves Incorporation of Wholly Owned Subsidiary Company in Dubai, United Arab Emirates
30/04	Dr. Lal Pathlabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026
30/04	Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
30/04	Dr. Lal PathLabs Limited agreed to acquire Shahbazkers Diagnostic Centre Private Limited for INR 200 million.
30/01	Dr. Lal PathLabs Consolidated Profit Declines in Fiscal Q3, Declares Third Interim Dividend
30/01	Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
30/01	Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong
30/01	Dr. Lal PathLabs Limited Approves the Declaration of Third Interim Dividend for the Financial Year 2025 - 2026, Payment Shall Be on February 5, 2026
30/01	Dr. Lal PathLabs Q3 consol net profit 905 million rupees
08/01	Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD Test in India
07/01	Cardio Diagnostics Holdings, Inc, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD Test in India
07/01	Top Premarket Gainers
06/01	Dr. Lal PathLabs Limited Launches Sovaaka
06/01	Dr. Lal PathLabs Launches New Diagnostic Experience Center in Gurugram, India
22/12	Indian Equities Extend Gains on Monday as Rupee Recovery, Foreign Inflows Lift Markets
22/12	Dr. Lal PathLabs Allotts Bonus Equity Shares in 1:1 Ratio
26/11	Dr. Lal PathLabs Opens Complement Testing Lab in India
26/11	Dr. Lal PathLabs Announces the Launch of India's First Dedicated Complement Testing Laboratory
31/10/25	Dr. Lal PathLabs' Fiscal Q2 Profit Rises; Declares Second Interim Dividend
31/10/25	Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025